GO:0043435 response to corticotropin-releasing hormone: Stress Axis Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043435 describes any cellular or organismal change triggered by corticotropin-releasing hormone (CRH), the master peptide hormone of the stress response.
• CRH is released from the hypothalamus and initiates the hypothalamic-pituitary-adrenal (HPA) axis, driving ACTH and cortisol secretion.
• CRH signaling is modulated by CRH-binding protein (CRHBP), which sequesters the peptide and buffers stress responses across species.
• Beyond the brain, CRH directly modulates immune cells such as macrophages, enhancing inflammatory responsivity.
• Dysregulated CRH responses are implicated in cocaine dependence, behavioral stress disorders, and endocrine tumors such as corticotroph-like somatotroph adenomas.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of CRH pathway genes in stress-related disease.
Description
Corticotropin-releasing hormone (CRH) is a peptide hormone that coordinates the body's response to stress, acting as the primary hypothalamic driver of the HPA axis. The Gene Ontology term GO:0043435, response to corticotropin-releasing hormone, captures any process that changes a cell or organism's state or activity in response to a CRH stimulus, including movement, secretion, enzyme production, and gene expression. This term is central to neuroendocrinology because CRH sits at the apex of the stress system, integrating neural and endocrine signals that affect metabolism, immunity, and behavior. Researchers study GO:0043435 to understand how acute and chronic stress are transduced at the molecular level. CRH is released into the hypophyseal portal system, where it binds CRHR1 on pituitary corticotrophs to stimulate ACTH secretion, which in turn raises cortisol. CRH also acts outside the classical axis: in zebrafish, CRH enhances macrophage responsiveness to inflammation, linking stress to innate immunity. The peptide's bioavailability is controlled by CRH-binding protein (CRHBP), a secreted decoy that modulates stress responses from invertebrates to humans. Because CRH signaling intersects with psychiatric, endocrine, and immune disorders, GO:0043435 is a high-value target for functional genomics. Human CRH infusion studies reveal altered stress responses in cocaine-dependent individuals, and CRH responsiveness can identify specific pituitary adenoma subtypes. CRISPR-based models now allow precise interrogation of CRH pathway components, making this GO term a practical framework for hypothesis-driven research.
response to corticotropin-releasing hormone At A Glance
| GO ID | GO:0043435 |
|---|---|
| GO term | response to corticotropin-releasing hormone |
| Ontology | biological_process |
| Synonym | response to corticoliberin stimulus; response to corticotropin-releasing factor stimulus; response to corticotropin-releasing hormone stimulus; response to CRF stimulus; response to CRH stimulus |
| Major function | Mediates cellular and organismal changes triggered by CRH, including HPA axis activation, ACTH secretion, immune modulation, and behavioral stress responses |
| Key ligand | Corticotropin-releasing hormone (CRH), a 41-amino-acid peptide hormone |
| Primary receptors | CRHR1 and CRHR2, G-protein-coupled receptors that initiate downstream signaling |
| Regulatory protein | CRH-binding protein (CRHBP) sequesters CRH and modulates its bioavailability |
| Physiological outcome | Glucocorticoid secretion, metabolic mobilization, and stress-related behavioral adaptation |
What Is GO:0043435?
GO:0043435, response to corticotropin-releasing hormone, is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticotropin-releasing hormone stimulus. Corticotropin-releasing hormone is a peptide hormone involved in the stress response. In practice, this term encompasses the molecular, cellular, and physiological changes triggered when CRH binds its receptors or otherwise acts on target tissues, including pituitary ACTH release, neuronal activation, immune modulation, and behavioral adaptation.
Why Is response to corticotropin-releasing hormone Important in Cell Biology?
GO:0043435 is important because CRH is the apex regulator of the stress system, and its response pathway determines how organisms cope with acute and chronic stressors. Dysregulation of CRH signaling is linked to psychiatric disorders, substance use disorders, and endocrine tumors, making this process a translational research priority. Understanding the molecular events downstream of CRH also informs immune-endocrine crosstalk, as shown by CRH-enhanced macrophage inflammation in zebrafish. Because the pathway is conserved and experimentally tractable, it serves as a model for studying neuropeptide action, receptor pharmacology, and stress-related disease mechanisms.
• CRH initiates the HPA axis, the central neuroendocrine stress response system.
• CRHBP modulates CRH bioavailability and stress resilience across species.
• CRH directly enhances macrophage inflammatory responsivity, linking stress to immunity.
• Altered CRH response is observed in cocaine-dependent individuals, implicating the pathway in addiction.
• CRH responsiveness helps identify corticotroph-like somatotroph adenomas in acromegaly.
• CRH and cortisol coordinate acute stress-induced behavioral responses in zebrafish.
• The pathway is conserved from invertebrates to humans, enabling comparative studies.
• CRH signaling is a target for drug development in stress-related disorders.
• GO:0043435 provides a structured framework for functional genomics of stress.
• CRISPR models can causally test CRH pathway genes in disease contexts.
What Happens During response to corticotropin-releasing hormone?
CRH Synthesis and Release
In simple terms: The brain makes CRH and releases it when stress is detected.
CRH is synthesized in the paraventricular nucleus of the hypothalamus and released into the hypophyseal portal circulation in response to stressors. This release is the first step in the HPA axis cascade, and it is tightly regulated by neural inputs and feedback from glucocorticoids. The peptide is also produced in extrahypothalamic sites, where it acts as a neuromodulator.
Receptor Binding and Activation
In simple terms: CRH binds to receptors on target cells, switching them on.
CRH binds to CRHR1 and CRHR2, which are G-protein-coupled receptors expressed on pituitary corticotrophs and other cell types. Ligand binding activates adenylyl cyclase, raises cAMP, and triggers downstream signaling cascades that alter gene expression and secretion. In macrophages, CRH enhances responsivity to inflammatory stimuli, demonstrating receptor-mediated effects beyond the pituitary.
ACTH Secretion and Cortisol Production
In simple terms: The pituitary releases ACTH, which tells the adrenal glands to make cortisol.
Activation of CRHR1 on pituitary corticotrophs stimulates the secretion of adrenocorticotropic hormone (ACTH) into the systemic circulation. ACTH acts on the adrenal cortex to promote glucocorticoid synthesis and release, primarily cortisol in humans. This endocrine output is the classic readout of GO:0043435 and is essential for metabolic and immune adaptation to stress.
Behavioral and Immune Modulation
In simple terms: CRH also changes behavior and immune cell activity.
Beyond the HPA axis, CRH influences behavioral responses to stress, as shown in zebrafish where CRH and cortisol coordinate acute stress-induced behavior. CRH also acts on immune cells: in zebrafish, CRH enhances macrophage responsivity to inflammation. These pleiotropic effects illustrate that GO:0043435 encompasses diverse cell types and physiological systems.
Feedback Regulation and CRHBP Buffering
In simple terms: The system has brakes, including a protein that soaks up CRH.
Glucocorticoids exert negative feedback on the hypothalamus and pituitary to restrain CRH and ACTH secretion. Additionally, CRH-binding protein (CRHBP) binds CRH in the circulation and extracellular space, reducing its availability to receptors and buffering stress responses. This dual regulation ensures that the response to CRH is proportional to the stressor and self-limiting.
Key Genes Involved in GO:0043435 response to corticotropin-releasing hormone
The following genes and proteins are central to the response to corticotropin-releasing hormone (GO:0043435), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CRH | Encodes corticotropin-releasing hormone, the primary ligand initiating the stress response | Knockout and overexpression models to study stress axis activation |
| CRHR1 | Encodes CRH receptor 1, mediates pituitary ACTH secretion and neuronal CRH signaling | Target for point mutations and knockouts in HPA axis studies |
| CRHR2 | Encodes CRH receptor 2, modulates stress-related behaviors and cardiovascular function | Knockout models to dissect receptor-specific effects |
| CRHBP | Encodes CRH-binding protein, sequesters CRH and buffers stress responses | Knock-in and overexpression models to study CRH bioavailability |
| POMC | Encodes proopiomelanocortin, precursor of ACTH in corticotrophs | CRISPR knockout to block ACTH production |
| NR3C1 | Encodes glucocorticoid receptor, mediates negative feedback on CRH | Point mutations to study feedback resistance |
| NR3C2 | Encodes mineralocorticoid receptor, modulates stress appraisal | Knockout models for stress-related behavior |
| AVP | Encodes arginine vasopressin, synergizes with CRH to drive ACTH release | Double knockout with CRH to study co-regulation |
| FKBP5 | Encodes FKBP51, regulates glucocorticoid receptor sensitivity | Knock-in models for stress resilience |
| MC2R | Encodes ACTH receptor on adrenal cortex, mediates cortisol synthesis | Knockout to study adrenal responsiveness |
| CYP11B1 | Encodes steroid 11-beta-hydroxylase, catalyzes cortisol synthesis | Point mutations to model cortisol deficiency |
| BDNF | Encodes brain-derived neurotrophic factor, modulated by CRH in stress circuits | Overexpression to study stress-related neuroplasticity |
| TNF | Encodes tumor necrosis factor, inflammatory mediator influenced by CRH | Knockout in immune cells to study CRH-immune crosstalk |
| IL6 | Encodes interleukin-6, cytokine modulated by CRH in inflammation | CRISPR knockout to test CRH-driven inflammation |
| GABRA1 | Encodes GABA-A receptor subunit, regulates CRH neuronal excitability | Point mutations to study stress circuit inhibition |
| SLC6A4 | Encodes serotonin transporter, interacts with CRH in stress behavior | Knockout models for addiction and stress |
| TH | Encodes tyrosine hydroxylase, involved in catecholamine response to stress | Overexpression to study stress-induced behavior |
| SST | Encodes somatostatin, modulates pituitary somatotroph function | Knockout to study adenoma subtypes |
How Is response to corticotropin-releasing hormone Regulated?
The response to corticotropin-releasing hormone is regulated at multiple levels. Glucocorticoids provide negative feedback by suppressing CRH and ACTH secretion through glucocorticoid receptor (NR3C1) signaling. CRH-binding protein (CRHBP) sequesters CRH, reducing receptor activation and buffering the stress response. Additionally, arginine vasopressin (AVP) synergizes with CRH to enhance ACTH release, while GABAergic and serotonergic inputs modulate CRH neuronal activity. In immune cells, CRH responsiveness is tuned by inflammatory mediators, as shown in zebrafish macrophages. These layers of regulation ensure that GO:0043435 is context-dependent and self-limiting.
response to corticotropin-releasing hormone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CRH | Stress-related psychiatric disorders and addiction | CRH knockout and overexpression cell models |
| CRHR1 | HPA axis dysregulation and anxiety | CRHR1 point-mutation knock-in models |
| CRHBP | Stress resilience and mood disorders | CRHBP overexpression and knockout models |
| NR3C1 | Glucocorticoid resistance and depression | NR3C1 point-mutation models |
| SST | Corticotroph-like somatotroph adenomas | SST knockout pituitary cell models |
Stress-Related Psychiatric Disorders
Dysregulation of CRH signaling is implicated in stress-related psychiatric conditions. Human CRH infusion studies show altered stress responses in cocaine-dependent individuals, linking the pathway to addiction. Chronic stress and CRH overactivity are associated with anxiety and mood disorders, where HPA axis feedback is impaired. These findings position GO:0043435 as a mechanistic hub for psychiatric disease research.
Endocrine Tumors
CRH responsiveness can distinguish pituitary adenoma subtypes. In acromegaly, GH responsiveness to CRH identifies corticotroph-like somatotroph adenomas, which has diagnostic and therapeutic implications. This demonstrates that the CRH response pathway is not only physiological but also a marker of endocrine tumor biology.
Inflammatory and Immune Conditions
CRH directly modulates immune cell function. In zebrafish, CRH enhances macrophage responsivity to inflammation, suggesting that stress can amplify inflammatory responses. This crosstalk may contribute to stress-related exacerbation of inflammatory diseases, making GO:0043435 relevant to neuroimmunology.
From response to corticotropin-releasing hormone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CRH drive ACTH secretion in pituitary cells? | CRH knockout and CRHR1 knockout cell lines |
| How does CRHBP modulate CRH bioavailability? | CRHBP overexpression and knock-in models |
| What is the effect of CRH on macrophage inflammation? | CRH-treated macrophage cell lines with TNF/IL6 reporters |
| Does a point mutation in CRHR1 alter cAMP signaling? | CRHR1 point-mutation knock-in cells |
| How does glucocorticoid feedback regulate CRH? | NR3C1 knockout and point-mutation models |
| Can CRH responsiveness identify adenoma subtypes? | SST knockout and CRH-stimulated pituitary cell models |
How to Study the response to corticotropin-releasing hormone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes after CRH stimulation | Identifying CRH-responsive transcripts |
| ELISA | ACTH and cortisol secretion | Validating HPA axis activation in cell models |
| cAMP reporter assay | CRHR1 signaling activity | Screening for receptor modulators |
| CRISPR knockout screen | Genes required for CRH response | Functional genomics of stress pathways |
| Live-cell imaging | Receptor trafficking and localization | Visualizing CRHR1 dynamics |
| Behavioral tracking | Stress-induced behavioral changes | Zebrafish models of CRH action |
| Proteomics | Protein expression and post-translational changes | Mapping CRH signaling networks |
| Flow cytometry | Immune cell activation markers | Macrophage responsivity to CRH |
Transcriptomic Profiling
RNA-seq after CRH stimulation measures changes in gene expression that define GO:0043435. This approach can identify CRH-responsive genes in pituitary, neuronal, and immune cells, revealing downstream effectors of the stress response. Differential expression analysis of CRH-treated versus control cells provides a genome-wide view of the pathway.
Hormone Secretion Assays
ELISA and radioimmunoassay quantify ACTH and cortisol release from pituitary and adrenal cells following CRH stimulation. These assays are the classic functional readout of HPA axis activation and are used to validate CRISPR models of CRH pathway genes.
Imaging and Reporter Systems
Live-cell imaging with cAMP reporters or fluorescently tagged CRHR1 allows real-time visualization of CRH receptor activation and trafficking. In zebrafish, behavioral imaging tracks stress-induced responses, linking molecular events to organismal behavior.
CRISPR Functional Genomics
Pooled CRISPR knockout screens can identify genes that modify cellular responses to CRH. By treating libraries of knockout cells with CRH and measuring survival, reporter activity, or secretion, researchers can map the genetic network underlying GO:0043435.
How CRISPR Can Be Used to Study GO:0043435 response to corticotropin-releasing hormone
Knockout
CRISPR knockout of CRH, CRHR1, or CRHBP in cell models abolishes or alters the response to CRH, providing causal evidence for their roles in GO:0043435. Knockout pituitary cells fail to secrete ACTH upon CRH stimulation, validating the pathway. Knockout macrophages show reduced inflammatory responsivity, confirming CRH-immune crosstalk.
Point Mutation
Point mutations in CRHR1 or NR3C1 can mimic human variants that alter receptor signaling or feedback sensitivity. These models help dissect how specific amino acid changes affect CRH response and disease risk. For example, mutations in the CRHR1 ligand-binding domain can impair cAMP induction.
Knock-in
Knock-in of tagged CRH or CRHR1 allows tracking of protein localization and interactions in live cells. Tagged knock-in models are valuable for imaging CRH release and receptor internalization, providing spatiotemporal insight into GO:0043435.
Overexpression
Overexpression of CRH or CRHBP in cell lines creates gain-of-function models to study excessive or buffered stress signaling. CRH overexpression drives constitutive ACTH secretion, while CRHBP overexpression blunts CRH responses, offering tools to test therapeutic strategies.
How EDITGENE Supports response to corticotropin-releasing hormone Research
Researchers studying response to corticotropin-releasing hormone-related genes often need to determine whether a candidate gene is causally involved in CRH signaling, HPA axis regulation, or stress-related disease. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible interrogation of GO:0043435 at the genetic level.
Contact EDITGENE today to design your custom CRISPR model for response to corticotropin-releasing hormone research.
Frequently Asked Questions About response to corticotropin-releasing hormone
What is GO:0043435 response to corticotropin-releasing hormone?
GO:0043435 is a Gene Ontology biological process term describing any change in a cell or organism's state or activity as a result of a corticotropin-releasing hormone (CRH) stimulus, including secretion, gene expression, and movement.
What genes are involved in response to corticotropin-releasing hormone?
Key genes include CRH, CRHR1, CRHR2, CRHBP, POMC, NR3C1, and AVP, which together mediate CRH synthesis, receptor signaling, ACTH secretion, and feedback regulation.
How does CRH trigger the stress response?
CRH is released from the hypothalamus, binds CRHR1 on pituitary corticotrophs, and stimulates ACTH secretion, which drives cortisol production from the adrenal glands.
What is the role of CRH-binding protein in stress?
CRHBP binds and sequesters CRH, reducing its availability to receptors and buffering the stress response across species from invertebrates to humans.
Can CRH affect immune cells?
Yes, CRH enhances macrophage responsivity to inflammation, as demonstrated in zebrafish, linking stress to innate immune function.
How is the response to CRH studied in the lab?
Researchers use RNA-seq, ELISA for ACTH/cortisol, cAMP reporter assays, CRISPR knockout screens, and behavioral tracking in model organisms.
What diseases are linked to CRH signaling?
CRH signaling is linked to stress-related psychiatric disorders, cocaine dependence, and endocrine tumors such as corticotroph-like somatotroph adenomas.
What CRISPR models are used for CRH pathway research?
Knockout, point mutation, knock-in, and overexpression models of CRH, CRHR1, CRHBP, and NR3C1 are used to dissect the pathway.
Is CRH signaling conserved across species?
Yes, CRH and its binding protein are conserved from invertebrates to humans, enabling comparative studies of stress responses.
How does cortisol feedback regulate CRH?
Cortisol binds glucocorticoid receptors and suppresses CRH and ACTH secretion through negative feedback, preventing excessive stress axis activation.
Conclusion
GO:0043435, response to corticotropin-releasing hormone, defines the molecular and physiological changes triggered by CRH, the master regulator of the stress response. From HPA axis activation to immune modulation and behavioral adaptation, this process is central to understanding how organisms cope with stress. Dysregulation of CRH signaling is implicated in psychiatric disorders, addiction, and endocrine tumors, making it a high-priority research area. CRISPR-based cell models provide powerful tools to dissect the causal roles of CRH pathway genes. By combining knockout, point mutation, knock-in, and overexpression strategies with functional assays, researchers can translate GO:0043435 from ontology annotation to mechanistic and therapeutic insight.
References
- 1. Chrousos GP. 2009. Stress and disorders of the stress system.. Nat Rev Endocrinol 5(7):374-81 PMID: 19488073
- 2. Miller WL. 2018. The Hypothalamic-Pituitary-Adrenal Axis: A Brief History.. Horm Res Paediatr 89(4):212-223 PMID: 29719288
- 3. Ketchesin KD et al.. 2017. Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.. Stress 20(5):449-464 PMID: 28436309
- 4. van Heijningen J et al.. 2025. Corticotropin-releasing hormone enhances the responsivity of macrophages to inflammation in zebrafish.. Gen Comp Endocrinol 373:114815 PMID: 40957546
- 5. Smith MA et al.. 1989. Corticotropin-releasing hormone: from endocrinology to psychobiology.. Horm Res 31(1-2):66-71 PMID: 2656470
- 6. Faught E et al.. 2022. Coordinated Action of Corticotropin-Releasing Hormone and Cortisol Shapes the Acute Stress-Induced Behavioural Response in Zebrafish.. Neuroendocrinology 112(1):74-87 PMID: 33503614
- 7. Brady KT et al.. 2009. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.. Arch Gen Psychiatry 66(4):422-30 PMID: 19349312
- 8. Itoh H et al.. 2026. GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegaly.. Pituitary 29(4) PMID: 42384227
